4.5 Article

Androgen insensitivity syndrome

Journal

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.beem.2015.04.005

Keywords

disorder of sex development (DSD); androgen receptor; management; gonadal tumor; hormone replacement therapy

Funding

  1. NIHR Cambridge Biomedical Research Centre

Ask authors/readers for more resources

Androgen insensitivity syndrome (AIS) results from androgen receptor dysfunction and is a common cause of disorder of sex development. The AIS phenotype largely depends on the degree of residual androgen receptor (AR) activity. This review describes the molecular action of androgens and the range of androgen receptor gene mutations, essential knowledge to understand the pathogenesis of the complete and partial forms of this syndrome. A multidisciplinary approach is recommended for clinical management from infancy through to adulthood. Hormone replacement therapy is needed following gonadectomy. Patients who choose to retain the gonads are at risk of developing germ cell tumors for which sensitive circulating tumor markers may soon become available. Whilst the contribution of AR dysfunction to complete AIS is well understood, the involvement of the AR and associated proteins as contributors to partial AIS is an area of active research. Disorders of sex development such as AIS which are related to AR dysfunction offer a breadth of manifestations for the clinician to manage and opportunities for further research on the mechanism of androgen action. (C) 2015 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Anatomy & Morphology

Impact of COVID-19 on student attainment and pedagogical needs when undertaking independent scientific research

Jennie N. Jeyapalan, Victoria. James, David S. Gardner, Jennifer H. Lothion-Roy, Nigel P. Mongan, Catrin Sian Rutland

Summary: Research is an essential part of veterinary medicine degrees, and remote learning during the COVID-19 pandemic has affected the performance and experience of students. This study analyzed the outcomes and feedback of students who completed independent research projects, showing that the pandemic cohorts achieved higher grades with increased access to resources while facing challenges in workload management and conceptual exploration.

ANATOMIA HISTOLOGIA EMBRYOLOGIA (2023)

Article Cell Biology

Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods

Ayat Lashen, Michael S. Toss, Andrew R. Green, Nigel P. Mongan, Emad Rakha

Summary: This study compared several methods for scoring Ki67 in breast cancer, and found that quantifying Ki67-positive cells among 1000 tumor cells had the highest consistency between observers and was the most predictive of patient outcomes. The granular pattern of Ki67 expression was associated with poorer outcomes compared to other patterns.

HISTOPATHOLOGY (2022)

Review Pathology

Defining invasion in breast cancer: the role of basement membrane

Suzan F. Ghannam, Catrin Sian Rutland, Cinzia Allegrucci, Nigel P. Mongan, Emad Rakha

Summary: Basement membrane (BM) is an important structure separating the epithelium from the stroma, and its composition varies during different stages of breast development. In pathological conditions, the presence or absence of BM plays a crucial role in distinguishing in situ from invasive lesions. Although diagnostic techniques are evolving, BM is still considered a useful marker in ambiguous cases. This review discusses the structure, function, and clinical significance of BM in relation to breast lesions, with a focus on differentiating it from alternative pathological tissue.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Article Oncology

NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma

Jaclyn M. Kubala, Kristian B. Laursen, Ryan Schreiner, Ryan M. Williams, Johannes C. van der Mijn, Michael J. Crowley, Nigel P. Mongan, David M. Nanus, Daniel A. Heller, Lorraine J. Gudas

Summary: In clear cell renal cell carcinoma (ccRCC), overexpression of NDUFA4L2 contributes to ccRCC proliferation and survival. NDUFA4L2 enhances glycolysis and regulates mitochondrial-lysosomal associations in ccRCC. Knocking out NDUFA4L2 decreases lysosomal size and abundance in ccRCC cells.

CANCER BIOLOGY & THERAPY (2023)

Article Genetics & Heredity

Clinical and molecular significance of the RNA m(6)A methyltransferase complex in prostate cancer

Jennifer Lothion-Roy, Daisy B. Haigh, Anna E. Harris, Veronika M. Metzler, Mansour Alsaleem, Michael S. Toss, Yousif Kariri, Atara Ntekim, Brian D. Robinson, Francesca Khani, Lorraine J. Gudas, Cinzia Allegrucci, Victoria H. James, Srinivasan Madhusudan, Melissa Mather, Richard D. Emes, Nathan Archer, Rupert G. Fray, Emad Rakha, Jennie N. Jeyapalan, Catrin S. Rutland, Nigel P. Mongan, Corinne L. Woodcock

Summary: N-6-methyladenosine (m(6)A) is the most abundant internal mRNA modification and plays crucial roles in gene expression, RNA stability, splicing and translation. The components of the m(6)A modification have been implicated in diseases, including prostate cancer (PCa). This study investigated the expression and clinical significance of METTL3, METTL14, WTAP, and CBLL1 in PCa specimens and cell lines, and found that METTL3 and CBLL1 expression were associated with poorer PCa patient outcomes. Functional analysis revealed the roles of METTL3 in androgen receptor regulation and gene expression in PCa cells.

FRONTIERS IN GENETICS (2023)

Review Pharmacology & Pharmacy

Targeting DNA damage repair precision medicine strategies in cancer

Juliette Brownlie, Sanat Kulkarni, Mashael Algethami, Jennie N. Jeyapalan, Nigel P. Mongan, Emad A. Rakha, Srinivasan Madhusudan

Summary: DNA repair targeted therapeutics, such as PARP inhibitors, have shown promising results in the treatment of BRCA germline deficient breast and ovarian cancer. However, not all patients respond to this treatment due to intrinsic or acquired resistance. Therefore, the exploration of other synthetic lethality approaches, including ATM, ATR, and WEE1 inhibitors, is currently an active area in cancer research.

CURRENT OPINION IN PHARMACOLOGY (2023)

Article Cell Biology

Encapsulated papillary carcinoma of the breast: does it have a native basement membrane?

Suzan F. Ghannam, Catrin S. Rutland, Cinzia Allegrucci, Nigel P. Mongan, Emad Rakha

Summary: This study describes the geometric characteristics of the EPC capsule and provides evidence that it is a reactive process rather than a thickened native BM characteristic of normal and in situ lesions. The study supports the understanding that EPC is an indolent invasive carcinoma based on capsule characteristics.

HISTOPATHOLOGY (2023)

Article Cell Biology

Characteristics and prognostic significance of polo-like kinase-1 (PLK1) expression in breast cancer

Ayat G. Lashen, Michael S. Toss, Louisa Wootton, Andrew R. R. Green, Nigel P. Mongan, Srinivasan Madhusudan, Emad Rakha

Summary: This study aimed to evaluate the prognostic and predictive role of PLK1 in breast cancer (BC) and its molecular subtypes. The results showed that high PLK1 expression was significantly associated with better outcome in the whole cohort and luminal BC, but with poorer outcome in triple-negative breast cancer (TNBC).

HISTOPATHOLOGY (2023)

Review Pathology

Expression, assessment and significance of Ki67 expression in breast cancer: an update

Ayat Gamal Lashen, Michael S. Toss, Suzan Fathy Ghannam, Shorouk Makhlouf, Andrew Green, Nigel P. Mongan, Emad Rakha

Summary: Ki67 expression is an important and cost-effective surrogate marker for assessing tumour cell proliferation in breast cancer. It has prognostic and predictive value, especially in hormone receptor-positive, HER2-negative tumours. However, challenges exist in its routine clinical use and there is increasing criticism of its clinical utility. Overcoming these challenges and weighing the benefits against weaknesses are necessary to maximize its performance in breast cancer.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Article Immunology

Activated tissue resident memory T-cells (CD8+CD103+CD39+) uniquely predict survival in left sided immune-hot colorectal cancers

Shahd Talhouni, Wakkas Fadhil, Nigel P. Mongan, Lara Field, Kelly Hunter, Sogand Makhsous, Alexandre Maciel-Guerra, Nayandeep Kaur, Ausrine Nestarenkaite, Arvydas Laurinavicius, Benjamin E. Willcox, Tania Dottorini, Ian Spendlove, Andrew M. Jackson, Mohammad Ilyas, Judith M. Ramage

Summary: The characterization of the tumour immune infiltrate, specifically CD8+ T-cells, has a strong predictive survival value for cancer patients. A study found that the abundance and localization of activated tumour-specific tissue resident memory CD8 T-cells (T-RM) can provide a higher-resolution route to patient stratification.

FRONTIERS IN IMMUNOLOGY (2023)

Article Cell Biology

The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer

Veronika M. Metzler, Simone de Brot, Daisy B. Haigh, Corinne L. Woodcock, Jennifer Lothion-Roy, Anna E. Harris, Emeli M. Nilsson, Atara Ntekim, Jenny L. Persson, Brian D. Robinson, Francesca Khani, Kristian B. Laursen, Lorraine J. Gudas, Michael S. Toss, Srinivasan Madhusudan, Emad Rakha, David M. Heery, Catrin S. Rutland, Nigel P. Mongan, Jennie N. Jeyapalan

Summary: KDM1A and KDM5B play crucial roles in prostate cancer by promoting androgen regulated gene expression through interaction with AR. Developing therapies targeting KDM1A and KDM5B is of great importance due to the ineffectiveness of conventional androgen deprivation therapies and androgen receptor signalling inhibitors in castrate resistant prostate cancer (CRPC).

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Article Oncology

Unravelling the clinicopathological and functional significance of replication protein A (RPA) heterotrimeric complex in breast cancers

Mashael Algethami, Michael S. S. Toss, Corinne L. L. Woodcock, Chandar Jaipal, Juliette Brownlie, Ahmed Shoqafi, Adel Alblihy, Katia A. A. Mesquita, Andrew R. R. Green, Nigel P. P. Mongan, Jennie N. N. Jeyapalan, Emad A. A. Rakha, Srinivasan Madhusudan

Summary: This study found that Replication Protein A (RPA) plays a critical role in breast cancer, being involved in cell DNA replication, checkpoint regulation and DNA repair. Low levels of RPA are associated with aggressive breast cancer and shorter survival outcomes. The study suggests that a precision oncology strategy targeting RPA is feasible in breast cancer patients.

NPJ BREAST CANCER (2023)

Article Oncology

Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence

Shorouk Makhlouf, Noorul Wahab, Michael Toss, Asmaa Ibrahim, Ayat G. Lashen, Nehal M. Atallah, Suzan Ghannam, Mostafa Jahanifar, Wenqi Lu, Simon Graham, Nigel P. Mongan, Mohsin Bilal, Abhir Bhalerao, David Snead, Fayyaz Minhas, Shan E. Ahmed Raza, Nasir Rajpoot, Emad Rakha

Summary: In this study, artificial intelligence (AI) was used to assess the prognostic significance of tumour infiltrating lymphocytes (TILs) in a large cohort of luminal breast cancer patients. The results showed that TILs counts and their spatial distribution had predictive value for the prognosis of early-stage breast cancer patients.

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level

N. M. Atallah, M. Alsaleem, M. S. Toss, N. P. Mongan, E. Rakha

Summary: HER2-positive breast cancer subtypes exhibit differential responses to targeted anti-HER2 therapy. Patients with IHC 2+/Amplified subtype have lower pathological complete response rates and shorter survival. ER positivity significantly decreases response to anti-HER2 therapy in IHC 2+/Amplified patients.

BRITISH JOURNAL OF CANCER (2023)

Review Oncology

Alternative Splicing Events and Their Clinical Significance in Colorectal Cancer: Targeted Therapeutic Opportunities

Mosebo Armstrong Manabile, Rodney Hull, Richard Khanyile, Thulo Molefi, Botle Precious Damane, Nigel Patrick Mongan, David Owen Bates, Zodwa Dlamini

Summary: Colorectal cancer is a leading cause of cancer-related deaths globally, with increasing incidence in developing countries. Dysregulated alternative splicing processes in colorectal cancer can promote its development and progression by producing proteins that activate cancer-promoting genes or deactivate cancer-inhibiting genes. It is important to identify these dysregulated alternative splicing genes in order to develop targeted treatments and diagnostics to stop cancer development and progression.

CANCERS (2023)

No Data Available